Simonian Nancy A

FollowCreate a free account to set a filing alert.

Director at ARQULE INC · on record since May 22, 2006
Chief Medical Officer at MILLENNIUM PHARMACEUTICALS INC · on record since Jun 11, 2007
Director at Generate Biomedicines, Inc. · on record since Feb 26, 2026
Director at Seagen Inc. · on record since Mar 21, 2012
Director at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
President & CEO at Syros Pharmaceuticals, Inc. · on record since Feb 13, 2017
Director at Evelo Biosciences, Inc. · on record since May 10, 2018

Insider trading activity of Simonian Nancy A

Transactions on record: 141; since May 15, 2006

Purchases: 0

Sales: 15; $2.1M

Companies traded: 6; last filing Mar 2, 2026

Figures computed from official regulatory filings — .

Companies where Simonian Nancy A has traded

Generate Biomedicines, Inc.1 tx · Mar 2, 2026
Syros Pharmaceuticals, Inc.53 tx · $717.9K · Dec 4, 2024
Seagen Inc.37 tx · $16.3M · Dec 15, 2023
Evelo Biosciences, Inc.3 tx · Jun 18, 2020
ARQULE INC5 tx · May 17, 2010
MILLENNIUM PHARMACEUTICALS INC42 tx · $4.9M · May 15, 2008

Track record of Simonian Nancy A

Insufficient history for a statistical track record (fewer than 5 purchases).

Transaction history of Simonian Nancy A

Co-insiders of Simonian Nancy A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Generate Biomedicines, Inc.Listing unverified	Mar 2, 2026	AwardD (derivative)	29,561	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 4, 2024	Sell	-37,070	0.27 USD	$10K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Nov 27, 2024	Sell	-134,713	0.27 USD	$36.4K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Nov 4, 2024	Exercise	40,125	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Nov 4, 2024	ExerciseD (derivative)	-40,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 7, 2024	Award	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	ExerciseD (derivative)	-39,566	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	Exercise	39,566	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	Other	-14,052	5.12 USD	$71.9K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	ExerciseD (derivative)	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	Exercise	6,000	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-3,676	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-8,750	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-7,038	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-3,171	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-3,462	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	Other	-62,753	229.00 USD	$14.4M	Unusual size	SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-2,044	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-28,001	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-29,399	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Generate Biomedicines, Inc.Listing unverified	Mar 2, 2026	AwardD (derivative)	29,561	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 4, 2024	Sell	-37,070	0.27 USD	$10K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Nov 27, 2024	Sell	-134,713	0.27 USD	$36.4K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Nov 4, 2024	Exercise	40,125	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Nov 4, 2024	ExerciseD (derivative)	-40,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 7, 2024	Award	4,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Jun 7, 2024	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	ExerciseD (derivative)	-39,566	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	Exercise	39,566	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	Other	-14,052	5.12 USD	$71.9K		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	ExerciseD (derivative)	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Syros Pharmaceuticals, Inc.Listing on record	Apr 2, 2024	Exercise	6,000	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-3,676	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-8,750	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-7,038	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-3,171	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-3,462	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	Other	-62,753	229.00 USD	$14.4M	Unusual size	SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-2,044	—	n/a (No price was disclosed in the filing)		SEC
Seagen Inc.Listing unverified	Dec 15, 2023	OtherD (derivative)	-9,260	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-28,001	—	n/a (No price was disclosed in the filing)		SEC
Syros Pharmaceuticals, Inc.Listing on record	Dec 5, 2023	OtherD (derivative)	-29,399	—	n/a (No price was disclosed in the filing)		SEC